Showing results (1661-1670 of 2,996) with videos related to
Sort By:
Pageof 300
Seminars in Thrombosis and Hemostasis|June 5, 1999
Hematologic complications of heparin-induced thrombocytopeniaM D RaibleSeminars in Thrombosis and Hemostasis|June 5, 1999
Coagulation laboratory testing in patients treated with argatrobanJ M Walenga, A R Fasanella, O Iqbal, et al.Seminars in Thrombosis and Hemostasis|August 10, 1999
Long-term activity of clopidogrel: a three-month appraisal in healthy volunteersH Caplain, R CariouSeminars in Thrombosis and Hemostasis|August 10, 1999
Pharmacokinetic profile of 14C-labeled clopidogrelR Lins, J Broekhuysen, J Necciari, et al.Seminars in Thrombosis and Hemostasis|August 10, 1999
Clopidogrel and drug metabolism: absence of effect on hepatic enzymes in healthy volunteersC H Pierce, J M Houle, J P Dickinson, et al.Seminars in Thrombosis and Hemostasis|August 10, 1999
Clopidogrel bioavailability: absence of influence of food or antacidsJ McEwen, G Strauch, P Perles, et al.Seminars in Thrombosis and Hemostasis|August 10, 1999
Clopidogrel, a novel antiplatelet agent, and digoxin: absence of pharmacodynamic and pharmacokinetic interactionP A Peeters, H J Crijns, W J Tamminga, et al.Seminars in Thrombosis and Hemostasis|May 11, 2000
Diagnosis of disseminated intravascular coagulation by hemostatic molecular markersH Wada, E Gabazza, T Nakasaki, et al.Seminars in Thrombosis and Hemostasis|May 11, 2000
Antithrombotic regulation in human endothelial cells by fibrinolytic factorsH Fukao, O MatsuoSeminars in Thrombosis and Hemostasis|May 11, 2000
Coagulation-associated enhancement of fibrinolytic activity via a neutralization of PAI-1 activityT Urano, H Ihara, Y Suzuki, et al.Pageof 300